Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
- PMID: 27403108
- PMCID: PMC4929363
- DOI: 10.1159/000444442
Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
Abstract
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by recurring abscesses, nodules, and fistulas predominantly in the groin and axillae. The association between HS and Crohn's disease (CD) has been well documented. Tumor necrosis factor (TNF) inhibitors have shown to be effective in treating both HS and CD. We report 2 patients who developed HS while on TNF inhibitor treatment for CD.
Keywords: Adalimumab; Crohn's disease; Hidradenitis Suppurativa.
Figures
References
-
- Danby FW, Margesson LJ. Hidradenitis suppurativa. Dermatol Clin. 2010;28:779–793. - PubMed
-
- Kamal N, Cohen BL, Buche S, Delaporte E, Colombel JF. Features of patients with Crohn's disease and hidradenitis suppurativa. Clin Gastroenterol Hepatol. 2016;14:71–79. - PubMed
-
- Kimball AB, Kerdel F, Adams D, et al. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012;157:846–855. - PubMed
-
- Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology. 2006;130:323–333. quiz 591. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
